BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18025118)

  • 1. Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media.
    Bellemare A; Vernoux N; Morisset D; Bourbonnais Y
    Antimicrob Agents Chemother; 2008 Feb; 52(2):483-90. PubMed ID: 18025118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function.
    Baranger K; Zani ML; Chandenier J; Dallet-Choisy S; Moreau T
    FEBS J; 2008 May; 275(9):2008-20. PubMed ID: 18341586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human pre-elafin mutants: full antipeptidase activity is essential to preserve lung tissue integrity in experimental emphysema.
    Doucet A; Bouchard D; Janelle MF; Bellemare A; Gagné S; Tremblay GM; Bourbonnais Y
    Biochem J; 2007 Aug; 405(3):455-63. PubMed ID: 17489739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens.
    Simpson AJ; Maxwell AI; Govan JR; Haslett C; Sallenave JM
    FEBS Lett; 1999 Jun; 452(3):309-13. PubMed ID: 10386612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and antimicrobial properties of human pre-elafin/trappin-2 and derived peptides against Pseudomonas aeruginosa.
    Bellemare A; Vernoux N; Morin S; Gagné SM; Bourbonnais Y
    BMC Microbiol; 2010 Oct; 10():253. PubMed ID: 20932308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases.
    Zani ML; Baranger K; Guyot N; Dallet-Choisy S; Moreau T
    Protein Sci; 2009 Mar; 18(3):579-94. PubMed ID: 19241385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris.
    Zani ML; Nobar SM; Lacour SA; Lemoine S; Boudier C; Bieth JG; Moreau T
    Eur J Biochem; 2004 Jun; 271(12):2370-8. PubMed ID: 15182352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supernatants of Pseudomonas aeruginosa induce the Pseudomonas-specific antibiotic elafin in human keratinocytes.
    Meyer-Hoffert U; Wichmann N; Schwichtenberg L; White PC; Wiedow O
    Exp Dermatol; 2003 Aug; 12(4):418-25. PubMed ID: 12930298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
    Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
    J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of human elafin.
    Shaw L; Wiedow O
    Biochem Soc Trans; 2011 Oct; 39(5):1450-4. PubMed ID: 21936832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family.
    Moreau T; Baranger K; Dadé S; Dallet-Choisy S; Guyot N; Zani ML
    Biochimie; 2008 Feb; 90(2):284-95. PubMed ID: 17964057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases.
    Guyot N; Bergsson G; Butler MW; Greene CM; Weldon S; Kessler E; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
    Biol Chem; 2010 Jun; 391(6):705-16. PubMed ID: 20370321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLPI and elafin: multifunctional antiproteases of the WFDC family.
    Scott A; Weldon S; Taggart CC
    Biochem Soc Trans; 2011 Oct; 39(5):1437-40. PubMed ID: 21936829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico study of whey-acidic-protein domain containing oral protease inhibitors.
    Idoji Y; Watanabe Y; Yamashita A; Yamanishi K; Nishiguchi S; Shimada K; Yasunaga T; Yamanishi H
    Int J Mol Med; 2008 Apr; 21(4):461-8. PubMed ID: 18360692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLPI and trappin-2 as therapeutic agents to target airway serine proteases in inflammatory lung diseases: current and future directions.
    Zani ML; Tanga A; Saidi A; Serrano H; Dallet-Choisy S; Baranger K; Moreau T
    Biochem Soc Trans; 2011 Oct; 39(5):1441-6. PubMed ID: 21936830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WAP domain proteins as modulators of mucosal immunity.
    Wilkinson TS; Roghanian A; Simpson AJ; Sallenave JM
    Biochem Soc Trans; 2011 Oct; 39(5):1409-15. PubMed ID: 21936824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of recombinant human elafin in the resistance of A549 cells against Pseudomonas aeruginosa biofilm.
    Li Q; Zhou X; Nie X; Yang J
    Respiration; 2010; 79(1):68-75. PubMed ID: 19420899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
    Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
    Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Villeret B; Solhonne B; Straube M; Lemaire F; Cazes A; Garcia-Verdugo I; Sallenave JM
    Front Immunol; 2020; 11():117. PubMed ID: 32117268
    [TBL] [